NVYTF / Novacyt receives EU approval for saliva-based Covid test

Novacyt S.A. (OTC:NVYTF) Q2 2023 Earnings Conference Call September 28, 2023 7:30 AM ET Company Participants James McCarthy - Acting CEO Steve Gibson more_horizontal

Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) is swooping to buy Yourgene Health PLC in a deal that values the latter at £16.7 million, or a 168% prem more_horizontal

Novacyt S.A. (OTCPK:NVYTF) Q4 2022 Results Conference Call April 27, 2023 7:00 AM ET Company Participants James McCarthy - Acting Chief Executive Offi more_horizontal

Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) said it has had a seventh Covid-19 test has been approved by the UK Health Security Agency. The genesig Co more_horizontal

Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV), the French biotech company, slipped 7% to 67p after confirming chief executive David Allmond will be step more_horizontal

Novacyt's rapid antigen test for Covid-19 has received a CE mark for the European Union, though it is still waiting for approval in the UK. David Allm more_horizontal

Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) shares slumped in early trading on Tuesday after the Department of Health & Social Care issued a claim aga more_horizontal

Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) said its real-time PCR test has been approved in the UK. The PROmate COVID-19 1G test is the company's more_horizontal